生物活性 | |||
---|---|---|---|
描述 | Atrasentan is an endothelin receptor antagonist (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.96mL 0.39mL 0.20mL |
9.79mL 1.96mL 0.98mL |
19.58mL 3.92mL 1.96mL |
参考文献 |
---|